Measuring standards of care for early breast cancer in an insured population

被引:50
作者
Hillner, BE
McDonald, MK
Penberthy, L
Desch, CE
Smith, TJ
Maddux, P
Glasheen, WP
Retchin, SM
机构
[1] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, MASSEY CANC CTR, RICHMOND, VA 23298 USA
[2] TRIGON BLUE CROSS BLUE SHIELD, RICHMOND, VA USA
关键词
D O I
10.1200/JCO.1997.15.4.1401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To demonstrate the use of a combined delta bose to evaluate the care for local/regional invasive breast cancer in a large insured population of women aged less than 64 years. Patients and Methods: We linked the procedural and hospital claims from Blue Cross Blue Shield (BCBS) of Virginia with clinical stage data from the Virginia Cancer Registry (VCR) from 1989 to 1991. A total of 918 women were assessed with a median age of 50 years; 68% had tumors less than 2 cm, 30% had positive axillary nodes, and 68% were assessed as having local summary stage. A quality-of-care "report card" was used based on standards of care from international Consensus Conferences. Results: Eight percent had a mastectomy as the initial biopsy procedure. Sixty-nine percent of women ultimately underwent mastectomy. Of those women who underwent lumpectomy, 86% had subsequent radiation, Within 3 months of diagnosis, 43% had a bone scan and 20% a computed tomography (CT) scan. Of women with positive axillary lymph nodes, 83% aged less than 51 years and 52% aged 51 to 64 years received chemotherapy. Fifty-six percent of all women held claims from a medical oncologist. Of women having a total mastectomy, 27% had claims from a plastic surgeon, Sixty-six percent to 76% of women had a mammogram, 24% a bone scan, and 14% a CT scan in the 0-18 and 18-36 month intervals following primary treatment. Conclusion: This study confirms the feasibility of linking sources of data that provide complementary information needed to develop measurements regarding standards of quality and efficiency of oncologic care, This report should serve as on initial benchmark while we await reports from other populations to define the best practice. (C) 1997 by American Society of Clinical Oncology.
引用
收藏
页码:1401 / 1408
页数:8
相关论文
共 35 条
  • [1] ABE O, 1992, LANCET, V339, P71
  • [2] Abeloff MD, 1995, CLIN ONCOLOGY, P1617
  • [3] DEVELOPMENT OF CLINICAL AND ECONOMIC PROGNOSES FROM MEDICARE CLAIMS DATA
    ANDERSON, G
    STEINBERG, EP
    WHITTLE, J
    POWE, NR
    ANTEBI, S
    HERBERT, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (07): : 967 - 972
  • [4] [Anonymous], 1985, JAMA, V254, P3461
  • [5] [Anonymous], 1992, Lancet, V339, P1
  • [6] 11 WORTHY AIMS FOR CLINICAL LEADERSHIP OF HEALTH SYSTEM REFORM
    BERWICK, DM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (10): : 797 - 802
  • [7] COILE R, 1996, HLTH TRENDS, V8, P1
  • [8] INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
    DELTURCO, MR
    PALLI, D
    CARIDDI, A
    CIATTO, S
    PACINI, P
    DISTANTE, V
    AZZINI, V
    BELSANTI, V
    BARTOLUCCI, R
    DICOSTANZO, F
    BERTUSI, M
    DANESE, S
    GIARDINA, G
    DAIUTO, G
    UCCELLO, V
    DELEO, G
    PUNZO, C
    GOSSO, P
    GRISO, C
    LOCATELLI, E
    MANSUTTI, M
    SANDRI, P
    MOLINO, AM
    SCHINCAGLIA, P
    TIENGHI, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20): : 1593 - 1597
  • [9] Factors that determine the treatment for local and regional prostate cancer
    Desch, CE
    Penberthy, L
    Newschaffer, CJ
    Hillner, BE
    Whittemore, M
    McClish, D
    Smith, TJ
    Retchin, SM
    [J]. MEDICAL CARE, 1996, 34 (02) : 152 - 162